ALIVUS LIFE SCIENCES
Back to Income Statement
|
ALIVUS LIFE SCIENCES Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,283 Cr | ₹2,161 Cr | ₹2,123 Cr | ₹1,885 Cr | ₹1,537 Cr |
What is the latest Revenue of ALIVUS LIFE SCIENCES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,283 Cr |
| Mar2024 | ₹2,161 Cr |
| Mar2023 | ₹2,123 Cr |
| Mar2022 | ₹1,885 Cr |
| Mar2021 | ₹1,537 Cr |
How is Revenue of ALIVUS LIFE SCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,283 Cr | 5.64 | |
| Mar2024 | ₹2,161 Cr | 1.79 | |
| Mar2023 | ₹2,123 Cr | 12.63 | |
| Mar2022 | ₹1,885 Cr | 22.63 | |
| Mar2021 | ₹1,537 Cr | - | |
Compare Revenue of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹10,855.9 Cr | -1.6% | -0.3% | -11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -1.6% |
-0.3% |
-11.9% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses